PDT Partners, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 1.5%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2021$45,000
-2.2%
10,585
-2.1%
0.00%0.0%
Q1 2021$46,000
-90.1%
10,809
-90.2%
0.00%
-91.9%
Q1 2020$463,000
+42.9%
110,300
+33.9%
0.04%
+85.0%
Q4 2019$324,000
-38.2%
82,364
+38.3%
0.02%
-35.5%
Q3 2019$524,00059,5420.03%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders